• Media type: E-Article
  • Title: Evaluation of national institute for health and care excellence guidance for ruptured abdominal aortic aneurysms by emulating a hypothetical target trial
  • Contributor: Eilenberg, Wolf; Waduud, Mohammed A.; Davies, Henry; Bailey, Marc A.; Scott, D. Julian A.; Wolf, Florian; Sotir, Anna; Lakowitsch, Sebastian; Kaider, Alexandra; Heinze, Georg; Brostjan, Christine; Domenig, Christoph M.; Neumayer, Christoph
  • imprint: Frontiers Media SA, 2023
  • Published in: Frontiers in Cardiovascular Medicine
  • Language: Not determined
  • DOI: 10.3389/fcvm.2023.1219744
  • ISSN: 2297-055X
  • Keywords: Cardiology and Cardiovascular Medicine
  • Origination:
  • Footnote:
  • Description: <jats:sec><jats:title>Objective</jats:title><jats:p>This retrospective study evaluates the performance of UK National Institute for Health and Care Excellence (NICE) Guidelines on management of ruptured abdominal aortic aneurysms in a “real world setting” by emulating a hypothetical target trial with data from two European Aortic Centers.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Clinical data was retrospectively collected for all patients who had undergone ruptured endovascular aneurysm repair (rEVAR) and ruptured open surgical repair (rOSR). Survival analysis was performed comparing NICE compliance to usual care strategy. NICE compliers were defined as: female patients undergoing rEVAR; male patients &amp;gt;70 years old undergoing rEVAR; and male patients ≤70 years old undergoing rOSR. Hemodynamic instability was considered additionally.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>This multicenter study included 298 patients treated for rAAA. The majority of patients were treated with rOSR (186 rOSR vs. 112 rEVAR). Overall, 184 deaths (68 [37%] with rEVAR and 116 [63%] with rOSR) were observed during the study period. Overall survival under usual care was 69.2% at 30 days, 56.5% at one year, and 42.4% at 5 years. NICE compliance gave survival outcomes of 73.1% at 30 days, 60.2% at 1 year and 42.9% at 5 years. The risk ratios at these time points, comparing NICE-compliance to usual care, were 0.88, 0.92 and 0.99, respectively.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>We support NICE recommendations to manage men below the age of 71 years and hemodynamic stability with rOSR. There was a slight survival advantage for NICE compliers overall, in men &amp;gt;70 years and women of all ages.</jats:p></jats:sec>
  • Access State: Open Access